Publication
Title
Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome : a review
Author
Abstract
The overactive bladder syndrome (OAB) negatively affects the daily life of many people. Conservative treatments, such as antimuscarinics, do not always lead to sufficient improvement of the complaints and/or are often associated with considerable side effects resulting in treatment failure. In the case of failure or intolerable side effects, sacral neuromodulation (SNM) and botulinum toxin are minimally invasive and reversible alternatives. Currently, of these alternatives only SNM with InterStimTM therapy has FDA approval for use in OAB patients. This review attempts to provide an update on the current position of SNM and botulinum toxin in the second-line management of adults with idiopathic OAB, based on the available clinical evidence concerning the efficacy and safety.
Language
English
Source (journal)
Urologia internationalis. - Basel
Publication
Basel : 2010
ISSN
0042-1138
Volume/pages
84:3(2010), p. 245-253
ISI
000276759900001
Full text (Publishers DOI)
Full text (publishers version - intranet only)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
External links
Web of Science
Record
Identification
Creation 03.10.2013
Last edited 10.04.2017